VC/I  TauTona Group

     Office Locations:

4040 Campbell Ave. Suite 110
Menlo Park, CA 94024
Phone: 650-331-2450
Fax: 650-331-2451



  • Early



  • Life Sciences & Healthcare
  • Medical Device



    The TauTona Group is a life-science incubator and investor focused on rapid development of innovative products, with special expertise in surgery, aesthetics and wound care. Co-founded in 2010 by two Stanford School of Medicine surgery professors, TauTona invests in and develops innovative medical devices for commercialization by strategic partners. Recent exits include the sale of the TauTona Tissue Injector to LifeCell, the sale of its Surgical Marker technology to Novadaq Technologies Inc., (NASDAQ: NVDQ) (TSX VENTURE: NDQ) and the sale of Aline HA to Allergan, Inc. (NYSE: AGN). TauTona also has several other devices currently under development or in the approval process.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Douglas T. Koo Managing Partner and Chief Financial Officer
    Geoffrey C. Gurtner MD Managing Partner
    Ken Horne Vice President
    Michael T. Longaker MD Partner
    Mike Rosenthal Vice President


    Portfolio companies include:


    Recent News: